| Authors: |
Qualls DA; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Lambert N; Department of Medicine, Baylor College of Medicine, Houston, TX., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Merrill M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pullarkat P; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Godby RC; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wehmeyer GT; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA., Amoozgar B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Leslie L; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abramson JS; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nowakowski GS; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rutherford SC; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Kahl B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Okwali M; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Buege MJ; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Seshan V; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY. |
